Pharmacists reinventing their roles to effectively respond to COVID-19: a global report from the international pharmacists for anticoagulation care taskforce (iPACT).
Journal
Journal of pharmaceutical policy and practice
ISSN: 2052-3211
Titre abrégé: J Pharm Policy Pract
Pays: England
ID NLM: 101627192
Informations de publication
Date de publication:
2020
2020
Historique:
received:
26
04
2020
accepted:
01
05
2020
entrez:
9
6
2020
pubmed:
9
6
2020
medline:
9
6
2020
Statut:
epublish
Résumé
SARS-CoV2 is dramatically impacting the global population. Worldwide, pharmacists are changing their roles and being increasingly recognized for their role as essential service providers. This commentary provides some examples collected from Asia, Europe, the Americas and Africa, ranging from essential services to meet human rights basic needs, extended generalist services developed to ensure continuity of care and supply of essential medicines to the development of differentiated extended responsibilities in emergency care. All examples were collected using a network of pharmacists from 27 countries, representing various areas of pharmacy practice, education and research and outreaching to include patient advocates. Selected services illustrate good practice, capability to adapt and contribution to universal health coverage. Above all, it demonstrates the commitment and innovation of the pharmaceutical workforce in the fight against COVID-19.
Identifiants
pubmed: 32509312
doi: 10.1186/s40545-020-00216-4
pii: 216
pmc: PMC7246962
doi:
Types de publication
Journal Article
Langues
eng
Pagination
12Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Competing interestsAll authors are members of iPACT, which has been funded by DRM-Foundation. There was no funding for the development of this commentary. The views expressed represent solely those involved in writing the commentary.
Références
J Pharm Policy Pract. 2020 Apr 20;13:8
pubmed: 32328285